A polymorphism in theCYP17 gene is associated with prostate cancer risk

This publication has 13 references indexed in Scilit:

• Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)
  Carcinogenesis: Integrative Cancer Research, 1999
• Association betweenCYP17 gene polymorphism and risk of breast cancer in young women
  International Journal of Cancer, 1999
• Molecular modelling of steroidogenic cytochromes P450 from families CYP11, CYP17, CYP19 and CYP21 based on the CYP102 crystal Structure
  The Journal of Steroid Biochemistry and Molecular Biology, 1998
• No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer
  British Journal of Cancer, 1998
• Early steps in androgen biosynthesis: From cholesterol to DHEA
  Bailliere's Clinical Endocrinology and Metabolism, 1998
• Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer
  JNCI Journal of the National Cancer Institute, 1996
• Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17
  Human Molecular Genetics, 1994
• Localization of the human CYP17 gene (cytochrome P45017α) to 10q24.3 by fluorescence in situ hybridization and simultaneous chromosome banding
  Genomics, 1992
• Promoter-specific activation of RNA polymerase II transcription by Sp1
  Trends in Biochemical Sciences, 1986
• The Development of Human Benign Prostatic Hyperplasia with Age
  Journal of Urology, 1984